General Information of the Compound
Compound ID
CP0143436
Compound Name
4-tert-butyl-N-[[4-(2H-tetrazol-5-yl)phenyl]methyl]benzamide
    Show/Hide
Structure
Formula
C19H21N5O
Molecular Weight
335.411
Canonical SMILES
CC(C)(C)c1ccc(cc1)C(=O)NCc1ccc(cc1)-c1nnn[nH]1
    Show/Hide
InChI
InChI=1S/C19H21N5O/c1-19(2,3)16-10-8-15(9-11-16)18(25)20-12-13-4-6-14(7-5-13)17-21-23-24-22-17/h4-11H,12H2,1-3H3,(H,20,25)(H,21,22,23,24)
    Show/Hide
InChIKey
LOLXXHNTLGCWRF-UHFFFAOYSA-N
Physicochemical Property
logP
3.0942
Rotatable Bonds
4
Heavy Atom Count
25
Polar Areas
83.56
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 137636686
ChEMBL ID
CHEMBL4063293
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01286, Bile acid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
EC50 = 120 nM
   TI
   LI
   LO
   TS